Cirrhosis - A Pathology-Based Teaching Guide

1. Definition

1. Diffuse fibrosis (fibrous septa bridging portal tracts and/or central veins)
2. Regenerative nodules (islands of hepatocytes attempting repair)
3. Disruption of the normal hepatic architecture (loss of the lobular and vascular organization)

Note: Cirrhosis ≠ Chronic liver failure. Not all cirrhosis leads to liver failure, and not all end-stage liver disease is cirrhotic. (e.g., primary biliary cholangitis, primary sclerosing cholangitis, and nodular regenerative hyperplasia may reach end-stage without fully established cirrhosis.) - Robbins & Cotran PBD

2. Etiology

3. Pathogenesis - The Core Mechanism

Step 1: The Key Cell - Hepatic Stellate Cells (Ito Cells)

• Normal state: HSCs reside quiescent in the Space of Disse (between hepatocytes and sinusoidal endothelial cells), storing retinoids (vitamin A) as lipid droplets.
• Activated state: In response to chronic liver injury, HSCs undergo a dramatic transformation:
  • Lose their vitamin A lipid droplets
  • Proliferate and develop prominent rough endoplasmic reticulum
  • Transform into contractile myofibroblasts (smooth muscle actin-positive)
  • Begin secreting extracellular matrix: collagen types I and III, sulfated proteoglycans, and glycoproteins

Step 2: Triggers of Stellate Cell Activation

• Kupffer cells (resident macrophages) release TGF-β, TNF-α, IL-1
• Damaged hepatocytes release reactive oxygen species (ROS), lipid peroxidation products
• Inflammatory cells (T cells, NK cells, NKT cells) release inflammatory cytokines
• TGF-β1 is the dominant pro-fibrotic cytokine
• PDGF (platelet-derived growth factor) is the main stimulus for stellate cell proliferation

Step 3: Progressive Fibrosis

• Deposition of collagen in the perisinusoidal space (normally collagen-free)
• Formation of fibrous septa linking portal tracts to each other (portal-portal bridging) or to central veins (portal-central bridging)
• Capillarization of sinusoids - loss of sinusoidal fenestrae and deposition of basement membrane → impairs exchange between blood and hepatocytes
• Ductular reactions - proliferating bile ductule-like structures appear, driven by progenitor cell activation; increase with disease progression and are most prominent in cirrhosis

Step 4: Nodular Regeneration

• Regenerating hepatocytes form discrete nodules (not lobules)
• The regenerative nodules have no proper central vein or portal tract - architecture is completely disorganized
• Adjacent nodules may coalesce over time

Fibrosis Regression (Important Concept)

4. Morphology

Gross Pathology

• A: Normal liver - smooth surface, homogeneous texture
• B: Normal histology - organized sinusoids, normal vascular structures
• C: Cirrhotic liver - orange-tawny color, irregular nodular surface
• D: Cirrhotic histology - disorganized architecture, regenerative nodules surrounded by fibrous tissue

Microscopic Pathology

• (A) Active cirrhosis: Thick bands of blue-stained collagen separating rounded cirrhotic nodules
• (B) After 1 year of abstinence: Most scars are gone, thin residual septa remain - demonstrates reversibility

Morphologic Classification (Nodule Size)

Important: This WHO morphologic classification has limited utility - the same pattern can arise from different etiologies, and the same etiology can show multiple patterns. Cirrhosis is a dynamic process in which nodule size changes over time. - Schwartz's Principles of Surgery

5. Consequences and Complications (Pathophysiology)

A. Portal Hypertension

1. Mechanical obstruction - fibrous bands and regenerative nodules compress and distort sinusoids and portal venules, increasing resistance to portal blood flow
2. Increased portal blood flow - peripheral and splanchnic vasodilation (mediated by nitric oxide and other vasodilators) causes a hyperdynamic circulation that further increases portal inflow

• Esophageal and gastric varices - collateral vessels at the gastroesophageal junction that can rupture catastrophically. The most feared acute complication - variceal hemorrhage is a leading cause of death.
• Caput medusae - dilated periumbilical collaterals from recanalization of the umbilical vein
• Hemorrhoids - collaterals at the anorectal junction
• Congestive splenomegaly → hypersplenism (thrombocytopenia, anemia, leukopenia)
• Ascites (see below)

B. Ascites

1. Portal hypertension → increased hydrostatic pressure in splanchnic capillaries
2. Hypoalbuminemia (liver failure) → reduced oncotic pressure
3. Splanchnic vasodilation → arterial underfilling → activation of renin-angiotensin-aldosterone system (RAAS) and ADH → sodium and water retention

C. Hepatic Encephalopathy

• The liver normally clears ammonia (from gut bacteria and amino acid metabolism) by converting it to urea. In cirrhosis + portosystemic shunting, ammonia bypasses the liver and reaches the brain.
• Other neurotoxins (mercaptans, short-chain fatty acids, false neurotransmitters) also contribute.
• Clinically: ranges from subtle personality changes → asterixis (flapping tremor) → coma.

D. Hepatorenal Syndrome

• Renal failure WITHOUT intrinsic renal pathology
• Mechanism: Hepatic failure → excess vasodilator production (nitric oxide) → reduced renal perfusion pressure → activation of renal sympathetic nervous system and RAAS → afferent arteriolar vasoconstriction → progressive renal failure
• Reversible if liver function is restored (e.g., by transplantation)

E. Hyperestrogenemia

• Spider angiomas (central pulsating arteriole with radiating vessels)
• Palmar erythema (local vasodilation)
• Gynecomastia and hypogonadism in males
• Menstrual irregularities in females

F. Coagulopathy

• Reduced synthesis of clotting factors (all factors except vWF are made in the liver)
• Thrombocytopenia from hypersplenism
• Vitamin K malabsorption (due to cholestasis)

G. Hepatocellular Carcinoma (HCC)

• Cirrhosis is the strongest risk factor for HCC, regardless of etiology
• Repeated cycles of cell death and regeneration → accumulation of genetic mutations → malignant transformation
• HBV-related HCC can arise without cirrhosis (HBV DNA integrates into the genome)
• Annual ultrasound surveillance is standard of care in cirrhotic patients

H. Other

• Bacterial infections/Spontaneous Bacterial Peritonitis (SBP) - Kupffer cell dysfunction + gut mucosal barrier damage → bacteremia → seeding of ascitic fluid
• Cholestasis and pruritus - persistent pruritus from bile salt accumulation can be profound and debilitating
• Jaundice - impaired bilirubin conjugation and excretion

6. Compensated vs. Decompensated Cirrhosis

7. Clinical Features Summary

1. Hepatic encephalopathy
2. Bleeding from esophageal varices
3. Bacterial infections (SBP, sepsis)
4. Hepatocellular carcinoma

8. Key Pathology Exam Points